Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Valproate dosage].

F P Meyer1, H Walther

  • 1Institut für Klinische Pharmakologie, Medizinischen Akademie Magdeburg.

Psychiatrie, Neurologie, Und Medizinische Psychologie
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

This study evaluates Valproate (VPA) dosage and serum levels to assess patient risk for acute hepatic failure. It questions whether aiming for Mattson et al.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rheumatoid arthritis - cardiovascular risk is high, but manageable].

Deutsche medizinische Wochenschrift (1946)·2013
Same author

Temperature dependence of the extinction coefficient of fused silica for CO(2) laser wavelengths.

Applied optics·2010
Same author

[Therapy of hypertension in the elderly].

Deutsche medizinische Wochenschrift (1946)·2006
Same author

Common-mode-free frequency comparison of lasers with relative frequency stability at the millihertz level.

Optics letters·2005
Same author

Limits on gravitational-wave emission from selected pulsars using LIGO data.

Physical review letters·2005
Same author

Nonsequential double ionization at the single-optical-cycle limit.

Physical review letters·2005
Same journal

[Comments on psychosomatic manifestations in ophthalmology].

Psychiatrie, Neurologie, und medizinische Psychologie·1990
Same journal

[Symptomatic myasthenia as a paraneoplastic syndrome in mixed-cell myelosis?].

Psychiatrie, Neurologie, und medizinische Psychologie·1990
Same journal

[Action and reaction elements as performance-modifying components of computer use in clinical psychology].

Psychiatrie, Neurologie, und medizinische Psychologie·1990
Same journal

[Clinical multiplicity of cerebrovascular disorders in childhood].

Psychiatrie, Neurologie, und medizinische Psychologie·1990
Same journal

[Endogenous psychoses in relation to absent phenylalanine hydroxylase activity in thrombocytes].

Psychiatrie, Neurologie, und medizinische Psychologie·1990
Same journal

[Pathology of inflammatory diseases of the central nervous system--an autopsy analysis 1967-1988].

Psychiatrie, Neurologie, und medizinische Psychologie·1990
See all related articles

Area of Science:

  • Pharmacology
  • Hepatology
  • Clinical Therapeutics

Background:

  • Valproate (VPA) is a widely used antiepileptic and mood-stabilizing drug.
  • Acute hepatic failure is a rare but serious adverse effect associated with VPA therapy.
  • Understanding optimal VPA serum levels is crucial for balancing efficacy and safety.

Purpose of the Study:

  • To analyze the relationship between Valproate dosage, serum levels, and the risk of acute hepatic failure.
  • To evaluate the therapeutic service's findings regarding VPA treatment.
  • To discuss the appropriateness of targeting a specific mean therapeutic blood level for VPA.

Main Methods:

  • Review of therapeutic service data.
  • Analysis of Valproate dosage recommendations.

Related Experiment Videos

  • Assessment of patient serum levels and hepatic failure risk.

    • Main Results:

    • The study presents results from a therapeutic service concerning Valproate dosage and serum levels.
    • Patient risk factors for acute hepatic failure in the context of Valproate therapy are examined.
    • Data is set forth to inform clinical decision-making.

    Conclusions:

    • The findings provide insights into managing Valproate therapy to minimize hepatic risks.
    • The study prompts a discussion on the optimal target serum concentration for Valproate.
    • Clinical practice may need to consider specific serum level targets, such as Mattson et al.'s proposal.